Richard Lewis
Ophthalmology · Sacramento, CANPI 1184798274
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $180,610 of the $261,616 with a category attached, or 69.0%. 19 manufacturers reported payments, led by Alcon at 54.9% of the total. Reporting peaked in 2022 at $77,967 and has fallen 99.7% since, to $258 in 2025. Among ophthalmology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $1301.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$144K
- Alcon Research LLC$59K
- Glaukos Corporation$36K
- Carl Zeiss Meditec, Inc.$10K
- Sight Sciences, Inc.$6K
- AbbVie$5K
- plus $3K from 13 others
Across 4 payments — averaging $1422.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ivantis, Inc$6K
What the payments were for
- Consulting fees$180,61069%
- Speaking & faculty fees$8,9003%
- Travel & lodging$6,0182%
- Food & beverage$6,9753%
- Education$1,0000%
- Other$58,11322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 83 | $143,527 |
| Alcon Research LLC | 48 | $59,231 |
| Glaukos Corporation | 11 | $35,591 |
| Carl Zeiss Meditec, Inc. | 11 | $9,608 |
| Sight Sciences, Inc. | 8 | $5,643 |
| AbbVie | 11 | $5,007 |
| Ivantis, Inc | 3 | $1,244 |
| Aerie Pharmaceuticals, Inc. | 12 | $1,188 |
| E.r. Squibb & Sons, L.L.C. | 1 | $126 |
| Dompe US, Inc. | 1 | $122 |
| Shire North American Group Inc | 2 | $117 |
| Novartis | 2 | $45 |
| Thea Pharma Inc. | 1 | $43 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $28 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $26 |
| Omeros Corporation | 1 | $20 |
| Kala Pharmaceuticals, Inc. | 1 | $19 |
| Iridex Corporation | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hydrus Microstent$122,362
- iStent Trabecular Micro-Bypass Stent System$35,000
- iStent inject Trabecular Micro-Bypass Stent System$35,000
- CyPass$23,450
- CIRRUS HD-OCT$7,800
- Humphrey FDT$5,200
- VISUCAM Fundus Cameras$5,200
- OMNI(R) SURGICAL SYSTEM (US)$3,852
- FORUM$2,600
- Humphrey HFA$2,600
- PLEX Elite 9000$2,600
- OMNI$1,725
- Hydrus$1,227
- Rhopressa$1,027
- Rocklatan$699
- Clareon$378
- XEN$368
- VERACITY SURGICAL$179
- Clareon PanOptix Pro$131
- Reblozyl$126
How this compares
$261,616 in reported general payments places this provider in the 95th percentile of 2,513 ophthalmology providers in California.
Other ophthalmology in Sacramento
- Samuel LeeSacramento$200K
- Daniel SchwartzSan Francisco$8M
- Michael BerlinWest Hollywood$5.7M
- Gilbert KlimanMenlo Park$1.5M
- Kuldev SinghStanford$1.5M
- Raymond DouglasBeverly Hills$1.3M
- John AffeldtLoma Linda$1.1M
- Srinivas SaddaPasadena$1M
- Sheri RowenNewport Beach$1M
- Savak TeymoorianLaguna Hills$955K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.